| P50 | author | Henry Nasrallah | Q90770563 |
| P2093 | author name string | Björn Paulsson | |
| | Martin Brecher | |
| P2860 | cites work | Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial | Q44299951 |
| | Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial | Q44385585 |
| | A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania | Q44565868 |
| | Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study | Q44874572 |
| | Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial | Q44915194 |
| | Quetiapine or haloperidol as monotherapy for bipolar mania--a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial | Q46683979 |
| | Depression in schizophrenia: perspective in the era of "Atypical" antipsychotic agents | Q30913196 |
| | Tolerability of atypical antipsychotics | Q33876248 |
| | Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine | Q34048732 |
| | Review of quetiapine and its clinical applications in schizophrenia | Q34182115 |
| | Suicide attempts associated with akathisia | Q34197618 |
| | The new generation of antipsychotic drugs: how atypical are they? | Q34245206 |
| | Extrapyramidal side effects are unacceptable | Q34392465 |
| | Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania | Q34552561 |
| | Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies | Q34558705 |
| | Efficacy of atypical antipsychotics in mood disorders | Q35165633 |
| | Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology | Q35180787 |
| | Safety and tolerability of emerging pharmacological treatments for bipolar disorder | Q36199036 |
| | The safety and tolerability of atypical antipsychotics in bipolar disorder | Q36235502 |
| | The many faces of Akathisia | Q40304062 |
| | Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety | Q44045819 |
| P433 | issue | 5 Pt 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | placebo | Q269829 |
| | extrapyramidal symptoms | Q1385411 |
| P304 | page(s) | 467-474 | |
| P577 | publication date | 2006-10-01 | |
| P1433 | published in | Bipolar Disorders | Q15716681 |
| P1476 | title | Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania | |
| P478 | volume | 8 | |